Mostrar el registro sencillo del ítem
dc.contributor.author | Jimenez-Jorge, Silvia | |
dc.contributor.author | Pozo Sanchez, Francisco | |
dc.contributor.author | Mateo-Ontañon, Salvador de | |
dc.contributor.author | Delgado-Sanz, Concepcion | |
dc.contributor.author | Casas Flecha, Inmaculada | |
dc.contributor.author | Garcia-Cenoz, Manuel | |
dc.contributor.author | Castilla Catalán, Jesús | |
dc.contributor.author | Sancho, R | |
dc.contributor.author | Etxebarriarteun-Aranzabal, L | |
dc.contributor.author | Quinones, C | |
dc.contributor.author | Martinez, E | |
dc.contributor.author | Vega, T | |
dc.contributor.author | Garcia, A | |
dc.contributor.author | Gimenez, J | |
dc.contributor.author | Vanrell, J M | |
dc.contributor.author | Castrillejo, D | |
dc.contributor.author | Larrauri, Amparo | |
dc.date.accessioned | 2020-02-03T08:58:39Z | |
dc.date.available | 2020-02-03T08:58:39Z | |
dc.date.issued | 2014-03-06 | |
dc.identifier.citation | Euro Surveill. 2014 Mar 6;19(9). pii: 20727. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/9005 | |
dc.description.abstract | Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses. | es_ES |
dc.description.sponsorship | This work was supported from the Influenza A(H1N1)pdm09 Programme of the Carlos III Institute of Health (GR09/0017 and PS12/00087). The GR09/0017 received additional funding from the World Health Organization Regional Office for Europe (WHO/Europe)/United States CDC (Centers for Disease Control and Prevention) and Epiconcept. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.mesh | Adolescent | es_ES |
dc.subject.mesh | Adult | es_ES |
dc.subject.mesh | Aged | es_ES |
dc.subject.mesh | Aged, 80 and over | es_ES |
dc.subject.mesh | Case-Control Studies | es_ES |
dc.subject.mesh | Child | es_ES |
dc.subject.mesh | Child, Preschool | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Infant | es_ES |
dc.subject.mesh | Influenza A Virus, H1N1 Subtype | es_ES |
dc.subject.mesh | Influenza A Virus, H3N2 Subtype | es_ES |
dc.subject.mesh | Influenza Vaccines | es_ES |
dc.subject.mesh | Influenza, Human | es_ES |
dc.subject.mesh | Logistic Models | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Middle Aged | es_ES |
dc.subject.mesh | Population Surveillance | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.subject.mesh | Vaccination | es_ES |
dc.subject.mesh | Young Adult | es_ES |
dc.subject.mesh | Outcome Assessment, Health Care | es_ES |
dc.title | Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study | es_ES |
dc.type | research article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 24626206 | es_ES |
dc.format.volume | 19 | es_ES |
dc.format.number | 9 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.es2014.19.9.20727 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | World Health Organization (WHO/OMS) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.es2014.19.9.20727 | es_ES |
dc.identifier.journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/PS12/00087 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/GR09/0017 | es_ES |
dc.rights.accessRights | open access | es_ES |